EdiLabs Joins Health Founders Estonia Accelerator

We are proud to announce that EdiLabs has been accepted into the first-ever Health Founders Estonia (HFE) accelerator 2025 cohort, joining 34 ambitious startups shaping the future of healthtech.

Over the next 12 months, EdiLabs will take part in the DEFINE programme, which is designed to support life science and healthtech companies at their earliest stages. For us, this means structured guidance to navigate the regulatory, clinical, technical, and business risks, with the support of Health Founders and its ecosystem of mentors, partners, and investors.

Our participation in HFE provides an opportunity to strengthen EdiLabs’ platform for edible biologics. With Health Founders’ backing, we will advance our scientific, clinical, and commercial foundations while building the partnerships needed to take our innovation to the next stage.

A unique aspect of the programme is its use of the CIMIT innovation framework (more here), a proven model created at Massachusetts General Hospital, Brigham and Women’s, and MIT to accelerate healthtech innovation. This structured approach helps startups like ours de-risk development and bring impactful therapies closer to patients.

We are excited to embark on this journey with Health Founders Estonia and to continue building towards our mission of making life-changing therapies globally accessible.

Learn more about the accelerator and the full cohort here: Health Founders Estonia announcement.

The HFE program is funded by the EU through Enterprise Estonia, in collaboration with Startup Estonia, to build a strong, globally competitive health tech ecosystem in Estonia.